Referencias

1. The national Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
2. Furlan AJ, Higashida RT, Wechsler L, Schulz, PROACT II Investigators. PROACT II: recombinant Prov-U-Sep (r-ProUK) in acute cerebral thromboembolism. Initial trial results. Stroke 1999;30:234. Abstract.
3. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T and the EMS Bridging Trial Investigators. Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke. Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605.
4. http://ww.ataquecerebral.cl